Stock listing
Frankfurt:Q84 Emyria Ltd Aktie
German listing (Frankfurt) of Emyria Ltd · home listing ASX:EMD
Follow Emyria Ltd into a list and get an email when it puts out news.
Home listing price · ASX:EMD
$0.032 AUD 0.000 (0.0%)
Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, ASX:EMD
- Day range
- $0.030 – $0.032 AUDNov 20, 2026
- Volume
- 513,307 sharesNov 20, 2026
- Market cap
- $25.81M AUDAt the close on Nov 20, 2026 · price × 806.7M shares outstanding
- 52-week range
- $0.030 – $0.070 AUDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $67,960 AUDMedian day 883,893 shares · 1 day with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| ASX:EMD · Home | $0.032 AUD | 0.000 (0.0%) | 513,307 | $0.032 | $0.032 | $0.030 | $0.032 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · ASX:EMD · AUD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.032 | 0.000 | 0.0% | $0.032 | $0.032 | $0.030 | 513,307 | |
| $0.032 | -0.002 | -5.9% | $0.035 | $0.035 | $0.030 | 2,245,134 | |
| $0.034 | -0.002 | -5.6% | $0.035 | $0.036 | $0.033 | 1,445,412 | |
| $0.036 | -0.001 | -2.7% | $0.037 | $0.038 | $0.036 | 2,904,896 | |
| $0.037 | -0.001 | -2.6% | $0.037 | $0.038 | $0.037 | 342,485 | |
| $0.038 | +0.001 | +2.7% | $0.036 | $0.040 | $0.036 | 1,319,061 | |
| $0.037 | +0.001 | +2.8% | $0.036 | $0.038 | $0.036 | 693,833 | |
| $0.036 | 0.000 | 0.0% | $0.036 | $0.036 | $0.036 | 473,417 | |
| $0.036 | -0.002 | -5.3% | $0.038 | $0.038 | $0.036 | 979,814 | |
| $0.038 | -0.002 | -5.0% | $0.039 | $0.039 | $0.038 | 838,183 | |
| $0.040 | +0.002 | +5.3% | $0.040 | $0.040 | $0.040 | 64,746 | |
| $0.038 | -0.002 | -5.0% | $0.038 | $0.039 | $0.038 | 232,943 | |
| $0.040 | 0.000 | 0.0% | $0.040 | $0.040 | $0.040 | 45 | |
| $0.040 | +0.001 | +2.6% | $0.039 | $0.040 | $0.039 | 413,341 | |
| $0.039 | 0.000 | 0.0% | $0.039 | $0.040 | $0.039 | 1,221,105 | |
| $0.039 | -0.002 | -4.9% | $0.042 | $0.042 | $0.039 | 1,180,167 | |
| $0.041 | +0.002 | +5.1% | $0.039 | $0.042 | $0.039 | 941,137 | |
| $0.039 | 0.000 | 0.0% | $0.039 | $0.039 | $0.039 | 129,884 | |
| $0.039 | 0.000 | 0.0% | $0.039 | $0.039 | $0.038 | 1,402,640 | |
| $0.039 | -0.005 | -11.4% | $0.042 | $0.042 | $0.037 | 3,542,687 | |
| $0.044 | +0.003 | +7.3% | $0.044 | $0.044 | $0.044 | 20,000 | |
| $0.041 | +0.002 | +5.1% | $0.040 | $0.041 | $0.040 | 340,489 | |
| $0.039 | -0.001 | -2.5% | $0.040 | $0.040 | $0.039 | 1,396,366 | |
| $0.040 | 0.000 | 0.0% | $0.041 | $0.041 | $0.040 | 478,700 | |
| $0.040 | 0.000 | 0.0% | $0.040 | $0.041 | $0.040 | 2,135,177 | |
| $0.040 | 0.000 | 0.0% | $0.040 | $0.041 | $0.040 | 417,433 | |
| $0.040 | -0.001 | -2.4% | $0.044 | $0.044 | $0.040 | 195,712 | |
| $0.041 | +0.002 | +5.1% | $0.040 | $0.043 | $0.040 | 499,630 | |
| $0.039 | -0.003 | -7.1% | $0.042 | $0.042 | $0.039 | 4,127,223 | |
| $0.042 | +0.001 | +2.4% | $0.043 | $0.043 | $0.041 | 1,316,919 | |
| $0.041 | -0.002 | -4.7% | $0.043 | $0.043 | $0.041 | 2,087,131 | |
| $0.043 | -0.002 | -4.4% | $0.046 | $0.046 | $0.043 | 771,249 | |
| $0.045 | +0.001 | +2.3% | $0.045 | $0.046 | $0.043 | 1,202,592 | |
| $0.044 | -0.001 | -2.2% | $0.046 | $0.046 | $0.044 | 197,603 | |
| $0.045 | 0.000 | 0.0% | $0.045 | $0.045 | $0.045 | 658,264 | |
| $0.045 | -0.001 | -2.2% | $0.048 | $0.048 | $0.045 | 709,919 | |
| $0.046 | 0.000 | 0.0% | $0.047 | $0.047 | $0.046 | 834,989 | |
| $0.046 | -0.001 | -2.1% | $0.048 | $0.048 | $0.046 | 2,790,075 | |
| $0.047 | -0.003 | -6.0% | $0.050 | $0.050 | $0.046 | 3,342,884 | |
| $0.050 | -0.001 | -2.0% | $0.050 | $0.050 | $0.049 | 2,471,183 | |
| $0.051 | +0.005 | +10.9% | $0.046 | $0.055 | $0.046 | 8,511,639 | |
| $0.046 | -0.002 | -4.2% | $0.048 | $0.048 | $0.046 | 841,527 | |
| $0.048 | 0.000 | 0.0% | $0.049 | $0.050 | $0.048 | 926,258 | |
| $0.048 | -0.002 | -4.0% | $0.050 | $0.053 | $0.048 | 3,637,788 | |
| $0.050 | +0.001 | +2.0% | $0.047 | $0.050 | $0.047 | 482,849 | |
| $0.049 | 0.000 | 0.0% | $0.050 | $0.050 | $0.046 | 2,024,263 | |
| $0.049 | -0.003 | -5.8% | $0.051 | $0.052 | $0.049 | 2,013,131 | |
| $0.052 | +0.005 | +10.6% | $0.048 | $0.054 | $0.048 | 7,941,863 | |
| $0.047 | -0.001 | -2.1% | $0.047 | $0.048 | $0.047 | 650,030 | |
| $0.048 | 0.000 | 0.0% | $0.048 | $0.048 | $0.047 | 1,284,797 | |
| $0.048 | 0.000 | 0.0% | $0.048 | $0.050 | $0.048 | 6,871,649 | |
| $0.048 | 0.000 | 0.0% | $0.048 | $0.050 | $0.046 | 2,274,645 | |
| $0.048 | +0.002 | +4.3% | $0.046 | $0.048 | $0.045 | 2,089,730 | |
| $0.046 | +0.002 | +4.5% | $0.044 | $0.046 | $0.043 | 514,666 | |
| $0.044 | -0.001 | -2.2% | $0.045 | $0.045 | $0.044 | 438,066 | |
| $0.045 | 0.000 | 0.0% | $0.045 | $0.045 | $0.045 | 0 | |
| $0.045 | -0.001 | -2.2% | $0.045 | $0.045 | $0.044 | 384,877 | |
| $0.046 | +0.001 | +2.2% | $0.046 | $0.046 | $0.045 | 284,076 | |
| $0.045 | -0.003 | -6.3% | $0.049 | $0.049 | $0.045 | 2,361,086 | |
| $0.048 | 0.000 | 0.0% | $0.048 | $0.049 | $0.048 | 1,098,789 | |
| $0.048 | +0.001 | +2.1% | $0.047 | $0.048 | $0.047 | 1,910,982 | |
| $0.047 | +0.002 | +4.4% | $0.045 | $0.047 | $0.045 | 808,290 | |
| $0.045 | -0.002 | -4.3% | $0.048 | $0.049 | $0.045 | 4,229,666 | |
| $0.047 | 0.000 | 0.0% | $0.048 | $0.048 | $0.047 | 129,403 | |
| $0.047 | 0.000 | 0.0% | $0.047 | $0.048 | $0.044 | 812,948 | |
| $0.047 | +0.003 | +6.8% | $0.046 | $0.047 | $0.045 | 678,010 |
- Ticker
- Frankfurt:Q84
- Asset type
- Stock
- Sector
- Health care
- Industry
- Health care services
- Exchange
- Frankfurt
- Currency
- EUR
What changed lately
Latest news release · Nov 18, 2026
Emyria Recruits 31 Therapists to Meet Growing Patient Demand
Latest deck · Nov 12, 2026
Shareholder Meeting (November 2026)
Shareholder meeting · 9 slides
Latest news
Emyria Recruits 31 Therapists to Meet Growing Patient Demand
Nov 18, 2026
Closed $0.032 (0.0%) on Nov 20, 2026
Change of Director's Interest Notice x 2
Nov 17, 2026
Closed $0.032 (-5.9%) on Nov 18, 2026
Application for quotation of securities - EMD
Nov 17, 2026
Closed $0.032 (-5.9%) on Nov 18, 2026
Final Director's Interest Notice - J. Tooke
Nov 12, 2026
Closed $0.037 (-2.6%) on Nov 13, 2026
Results of Annual General Meeting
Nov 12, 2026
Closed $0.037 (-2.6%) on Nov 13, 2026
2026 Annual General Meeting Presentation
Nov 11, 2026
Closed $0.038 (+2.7%) on Nov 12, 2026
Notification of cessation of securities - EMD
Nov 10, 2026
Closed $0.037 (+2.8%) on Nov 11, 2026
September 2026 Quarterly Investor Webinar Presentation
Nov 1, 2026
Closed $0.04 (+2.6%) on Nov 2, 2026
September 2026 Quarterly Investor Update Webinar Invitation
Oct 29, 2026
Closed $0.039 (0.0%) on Oct 30, 2026
September 2026 Quarterly Activities Report and Appendix 4C
Oct 28, 2026
Closed $0.039 (-4.9%) on Oct 29, 2026
Emyria Ltd on 6ix
- Sector
- Health care
- Industry
- Health care services
- News releases
- 51 in the last 12 months · 192 in all · newest Nov 18, 2026 · oldest 2020
- Decks
- 28 decks · latest Nov 12, 2026
Where Emyria Ltd is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| ASX:EMD · Home listing | ASX | Australia | AUD |
| Frankfurt:Q84 · This page | Frankfurt | Germany | EUR |
| OTC:EMYRF | OTC | United States | USD |
Valuation
EV/sales 5.0× against a median of 0.5×: the highest of 11 Health care services companies shown. Statements: Year to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- $19.31M AUD
- P/E
- Loss
- EV/sales
- 5.0×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 2.9×
- Gross margin
- −94.3%
- Operating margin
- −161.6%
- Net margin
- −157.6%
- Debt to equity
- 0.1×
- Beta
- No index for this market yet
Health care services: the 10 companies nearest in size, of 419 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Emyria Ltd · ASX:EMD | US$17.09M | US$12.78M | n/a | 5.0× | n/a | 2.9× | −157.6% | 0.1× | n/a |
| CareView Communications, Inc. · OTC:CRVW | US$18.98M | US$17.04M | n/a | 1.8× | 36.1× | n/a | −29.7% | n/a | -0.28 |
| Guangdong Kanghua Healthcare Group Co., Ltd. Class H · HKEX:3689 | US$18.84M | −US$16.21M | 1.3× | −0.1× | −0.4× | 0.1× | 4.9% | 0.3× | n/a |
| NeuPath Health Inc. · TSXV:NPTH | US$18.48M | US$19.65M | 19.7× | 0.3× | 6.1× | 1.1× | 1.5% | 0.2× | 0.08 |
| DocGo Inc. · NASDAQ:DCGO | US$17.32M | −US$1.59M | n/a | −0.0× | n/a | 0.2× | −61.0% | 0.0× | 1.48 |
| DC Healthcare Holdings Bhd · MYX:DCHCARE | US$16.97M | US$13.59M | 26.1× | 0.6× | 2.8× | 1.5× | 2.9% | 0.2× | n/a |
| Physitrack Limited · OMXSTO:PTRK | US$16.73M | US$20.84M | n/a | 1.4× | 4.4× | 1.5× | −57.9% | 0.4× | n/a |
| Lemon Healthcare Co. · KRX:365660 | US$16.49M | US$880,715 | n/a | 0.1× | n/a | 1.2× | −13.2% | 0.0× | n/a |
| Grand Brilliance Group Holdings Limited · HKEX:8372 | US$16.23M | US$9.58M | 15.1× | 0.8× | 8.0× | 1.1× | 8.3% | 0.0× | n/a |
| EBM Technologies Incorporated · TPEX:8409 | US$16.02M | US$11.90M | 67.7× | 1.6× | 17.0× | 1.8× | 3.1% | 0.0× | n/a |
| Farmaceutica Remedia SA · BVB:RMAH | US$15.37M | US$7.47M | 18.8× | 0.1× | 3.3× | 1.0× | 0.5% | 0.0× | n/a |
| Median of the others | US$16.85M | US$10.74M | 19.3× | 0.5× | 5.2× | 1.1× | 1.0% | 0.0× | 0.08 |
Team and board
Officers
| Officer | Role |
|---|---|
| Mary-Ann Rennie | Chief Operating Officer |
| Angela McGuire | General Manager - National Operations, Clinics |
| Claudia Sullivan | Head of Clinical Governance |
| Greg Hutchinson | Executive Chairman |
| Michael Winlo | Executive Director |
| Tatjana Heinrich | Head of Preclinical Drug Development |
Board
| Director | Role |
|---|---|
| Greg Hutchinson | Executive Chairman |
| John Tooke | Non-Executive Director |
| Karen Smith | Non-Executive Director |
| Michael Winlo | Executive Director |
| Mohit Kaushal | Non-Executive Director |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q4 2025 | Aug 27, 2025 | −9.4% |
| Q2 2025 | Feb 26, 2025 · After close | +3.1% |
| Q2 2023 | Feb 27, 2023 · Before open | −2.3% |
| Q4 2022 | Aug 29, 2022 · After close | 0.0% |
| Q2 2022 | Feb 28, 2022 · Before open | +5.7% |
| Q4 2021 | Aug 31, 2021 | 0.0% |
| Q2 2021 | Feb 24, 2021 | −7.0% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Shareholder Meeting (November 2026) | Shareholder meeting | 9 slides | Nov 12, 2026 |
| Q3 2026 Earnings Presentation | Earnings | 11 slides | Nov 2, 2026 |
| FY2026 Earnings Presentation | Earnings | 11 slides | Sep 8, 2026 |
| Investor Presentation (July 2026) | Investor deck | 22 slides | Jul 27, 2026 |
| Corporate Update (June 2026) | Corporate update | 24 slides | Jun 11, 2026 |
| Q1 2026 Earnings Presentation | Earnings | 13 slides | May 5, 2026 |
| Ignite Investment Summit Singapore 2026 | Conference | 15 slides | Apr 21, 2026 |
| Sharewise Webinar (October 2025) | Conference | 22 slides | Oct 15, 2025 |
| Investor Presentation (August 2025) | Investor deck | 23 slides | Aug 28, 2025 |
| Euroz Hartleys 2025 Healthcare Forum | Conference | 24 slides | Feb 4, 2025 |
All 28 decks
Financials
Annual, in AUD
Income statement
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.88M | 1.39M | 2.20M | 1.59M | 1.82M | 1.98M | 1.01M | 109.9K | 0 |
| Cost of revenue | 7.54M | 1.37M | 2.37M | 4.91M | 6.24M | 3.56M | 3.80M | 1.73M | |
| Gross profit | -3.66M | 24.5K | -167.5K | -3.32M | -4.41M | -1.58M | -2.79M | -1.62M | |
| Research and development | 531.1K | 812.2K | 2.09M | 1.80M | 2.21M | 2.62M | 1.51M | 221.5K | 221.5K |
| Selling, general and administrative | 5.26M | 3.52M | 3.43M | 3.43M | 4.61M | 1.95M | 2.25M | 477.6K | 184.9K |
| Operating income | -6.27M | -2.65M | -6.90M | -7.12M | -8.54M | -5.71M | -5.63M | -2.71M | -64.3K |
| Depreciation and amortization | 457.8K | 466.1K | 694.9K | 400.6K | 309.5K | 344.9K | 383.5K | 94.8K | 257.3K |
| EBITDA | -5.81M | -2.18M | -6.21M | -6.72M | -8.23M | -5.37M | -5.25M | -2.61M | 193.0K |
| Interest expense | 61.3K | 134.6K | 253.3K | 128.8K | 72.2K | 66.9K | 59.5K | 4.04K | 60 |
| Income before tax | -6.31M | -3.14M | -14.0M | -7.22M | -8.49M | -4.91M | -5.24M | -2.68M | -64.3K |
| Income tax | -191.1K | -2.53M | -2.09M | -1.16M | 5 | -1 | 4 | -120 | |
| Net income | -6.11M | -3.14M | -11.5M | -5.13M | -7.33M | -4.91M | -5.24M | -2.68M | -64.3K |
| Earnings per share, basic | -0.01 | -0.01 | -0.03 | -0.02 | -0.03 | -0.02 | -0.03 | -0.01 | -0.00 |
Balance sheet
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 7.29M | 3.57M | 1.57M | 2.73M | 3.88M | 6.53M | 3.69M | 2.61M | 3.04M |
| Receivables | 794.4K | 19.0K | 30.7K | 85.5K | 87.5K | 273.4K | 121.6K | 59.9K | 19.3K |
| Inventory | 329.3K | -3.41K | -59.9K | -19.3K | |||||
| Current assets | 8.53M | 3.81M | 1.93M | 2.85M | 4.12M | 6.88M | 3.84M | 2.67M | 3.06M |
| Property, plant and equipment | 819.8K | 1.26M | 496.0K | 1.08M | 1.28M | 921.7K | 706.5K | ||
| Goodwill | 1.32M | 1.56M | 1.56M | ||||||
| Total assets | 11.5M | 6.62M | 5.43M | 10.2M | 8.25M | 9.06M | 5.06M | 3.52M | 3.06M |
| Accounts payable | 945.8K | 369.9K | 504.0K | 1.12M | 619.1K | 245.5K | 149.0K | 148.4K | 242.9K |
| Current liabilities | 1.96M | 801.5K | 2.24M | 3.15M | 1.46M | 1.03M | 1.00M | 272.7K | 250.4K |
| Long-term debt | 0 | 2.75M | |||||||
| Total debt | 787.4K | 613.5K | 1.72M | 1.27M | 632.7K | 949.7K | 610.8K | 3.15M | |
| Total liabilities | 2.65M | 1.31M | 3.00M | 3.37M | 1.93M | 1.88M | 1.28M | 3.03M | 250.4K |
| Shareholders' equity | 8.85M | 5.31M | 2.43M | 6.79M | 6.32M | 7.18M | 3.78M | 499.5K | 2.81M |
| Shares outstanding | 739.8M | 448.6M | 359.0M | 289.4M | 268.6M | 220.2M | 173.8M | 195.3M | 195.3M |
Cash flow
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -4.56M | -2.70M | -4.28M | -3.77M | -5.43M | -3.94M | -4.45M | -2.59M | -20.8K |
| Capital spending | -366.2K | -13.9K | -159.1K | -3.23M | -2.03M | -661.4K | -201.8K | -844.8K | -844.8K |
| Free cash flow | -4.92M | -2.72M | -4.44M | -7.01M | -7.46M | -4.60M | -4.65M | -3.44M | -20.8K |
| Cash from investing | -546.6K | 81.1K | -1.38M | -3.23M | -2.03M | -661.4K | -201.8K | -901.1K | -901.1K |
| Cash from financing | 8.82M | 4.63M | 4.50M | 5.86M | 4.81M | 7.44M | 5.73M | 3.11M | 3.06M |
| Dividends paid | -62.6K | -767.7K | -341.8K | -527.4K | |||||
| Share buybacks | -523.8K | 5.73M | -139.4K | -320.0K | -527.5K | -527.5K | -742.7K | 0 | 3.06M |
| Change in cash | 3.72M | 2.00M | -1.17M | -1.15M | -2.65M | 2.84M | 971.3K | -324.4K | 3.04M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| Emyria Recruits 31 Therapists to Meet Growing Patient Demand | Nov 18, 2026 | Operations update | ASX |
| Change of Director's Interest Notice x 2 | Nov 17, 2026 | Ownership change notice | ASX |
| Application for quotation of securities - EMD | Nov 17, 2026 | Financing | ASX |
| Final Director's Interest Notice - J. Tooke | Nov 12, 2026 | Ownership change notice | ASX |
| Results of Annual General Meeting | Nov 12, 2026 | Meeting outcome | ASX |
| 2026 Annual General Meeting Presentation | Nov 11, 2026 | Annual report | ASX |
| Notification of cessation of securities - EMD | Nov 10, 2026 | Financing | ASX |
| September 2026 Quarterly Investor Webinar Presentation | Nov 1, 2026 | Quarterly report | ASX |
| September 2026 Quarterly Investor Update Webinar Invitation | Oct 29, 2026 | Meeting notice | ASX |
| September 2026 Quarterly Activities Report and Appendix 4C | Oct 28, 2026 | Quarterly report | ASX |
All 176 filings
Cap table
Built by 6ix from Emyria Ltd’s releases
- Common shares
- 806,686,029
- Fully diluted
- 806,686,029
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 806,686,029 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 806,686,029 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Angela McGuire | General Manager - National Operations, Clinics · Since at least Nov 4, 2026 |
| Claudia Sullivan | Head of Clinical Governance · Since at least Nov 4, 2026 |
| Greg Hutchinson | Executive Chairman · Since at least Aug 13, 2025 |
| John Tooke | Non-Executive Director · Since at least Oct 9, 2026 |
| Karen Smith | Non-Executive Director · Since at least Nov 5, 2026 |
| Mary-Ann Rennie | Chief Operating Officer · Since at least Nov 4, 2026 |
| Michael Winlo | Executive Director · Since at least Jun 18, 2025 |
| Mohit Kaushal | Non-Executive Director · Since at least Nov 5, 2026 |
| Tatjana Heinrich | Head of Preclinical Drug Development · Since at least Nov 4, 2026 |
Log in to ask 6ix AI your own questions about Emyria Ltd.